Atıf Formatları
Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. K. Erol Et Al. , "Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.945-950, 2017

Erol, M. K. Et Al. 2017. Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13 , 945-950.

Erol, M. K., Balkarli, A., Yucel, O., AKAR, Y., Dogan, B., & Suren, E., (2017). Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 945-950.

Erol, Muhammet Et Al. "Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 945-950, 2017

Erol, Muhammet K. Et Al. "Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.945-950, 2017

Erol, M. K. Et Al. (2017) . "Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.945-950.

@article{article, author={Muhammet Kazim Erol Et Al. }, title={Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy}, journal={THERAPEUTICS AND CLINICAL RISK MANAGEMENT}, year=2017, pages={945-950} }